Covered recipient · General Payments record

JANE SOYOUNG CLARK

Allopathic & Osteopathic Physicians Dermatology

NPI: 1659530004
CMS profile: 256950
Location: DALTON, GA

General Payments · PY2018–2024

$6,703.87

Reported across 354 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,056.10

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$991.15	53
Education	$64.95	1

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
NOVARTIS PHARMACEUTICALS CORPORATION	$165.21	10
Janssen Biotech, Inc.	$155.51	8
ABBVIE INC.	$137.37	10
GENZYME CORPORATION	$112.33	3
E.R. Squibb & Sons, L.L.C.	$103.48	5
Regeneron Healthcare Solutions, Inc.	$100.10	4
Lilly USA, LLC	$81.69	4
PFIZER INC.	$70.81	3
Galderma Laboratories, L.P.	$42.28	2
Boehringer Ingelheim Pharmaceuticals, Inc.	$35.42	2
Incyte Corporation	$22.58	1
MAYNE PHARMA COMMERCIAL LLC	$15.09	1
Amgen Inc.	$14.23	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$700.49	41
PY2019	$632.51	37
PY2020	$679.48	45
PY2021	$784.02	46
PY2022	$1,003.73	51
PY2023	$1,847.54	80
PY2024	$1,056.10	54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$3.93	03/06/2024	Food and Beverage	Undisputed	01/23/2026	1103476917	CMS
ABBVIE INC.	$7.70	04/10/2024	Food and Beverage	Undisputed	01/23/2026	1103476919	CMS
ABBVIE INC.	$23.35	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1103476921	CMS
ABBVIE INC.	$13.17	06/10/2024	Food and Beverage	Undisputed	01/23/2026	1103476923	CMS
ABBVIE INC.	$9.76	06/18/2024	Food and Beverage	Undisputed	01/23/2026	1103476925	CMS
ABBVIE INC.	$17.01	07/07/2024	Food and Beverage	Undisputed	01/23/2026	1103476927	CMS
ABBVIE INC.	$18.19	09/16/2024	Food and Beverage	Undisputed	01/23/2026	1103476929	CMS
ABBVIE INC.	$11.19	11/11/2024	Food and Beverage	Undisputed	01/23/2026	1103476931	CMS
ABBVIE INC.	$15.08	12/03/2024	Food and Beverage	Undisputed	01/23/2026	1103476933	CMS
ABBVIE INC.	$17.99	12/05/2024	Food and Beverage	Undisputed	01/23/2026	1103476935	CMS
Amgen Inc.	$14.23	11/21/2024	Food and Beverage	Undisputed	01/23/2026	1117225330	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$19.51	01/18/2024	Food and Beverage	Undisputed	01/23/2026	1118099292	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$15.91	05/02/2024	Food and Beverage	Undisputed	01/23/2026	1118099290	CMS
E.R. Squibb & Sons, L.L.C.	$24.30	02/20/2024	Food and Beverage	Undisputed	01/23/2026	1101283484	CMS
E.R. Squibb & Sons, L.L.C.	$21.35	03/19/2024	Food and Beverage	Undisputed	01/23/2026	1101283486	CMS
E.R. Squibb & Sons, L.L.C.	$16.07	05/03/2024	Food and Beverage	Undisputed	01/23/2026	1101283488	CMS
E.R. Squibb & Sons, L.L.C.	$23.60	05/03/2024	Food and Beverage	Undisputed	01/23/2026	1101283490	CMS
E.R. Squibb & Sons, L.L.C.	$18.16	12/12/2024	Food and Beverage	Undisputed	01/23/2026	1101283518	CMS
Galderma Laboratories, L.P.	$28.91	08/15/2024	Food and Beverage	Undisputed	01/23/2026	1145291176	CMS
Galderma Laboratories, L.P.	$13.37	10/24/2024	Food and Beverage	Undisputed	01/23/2026	1145291178	CMS
GENZYME CORPORATION	$43.07	01/29/2024	Food and Beverage	Undisputed	01/23/2026	1139769208	CMS
GENZYME CORPORATION	$36.43	03/26/2024	Food and Beverage	Undisputed	01/23/2026	1139769220	CMS
GENZYME CORPORATION	$32.83	11/18/2024	Food and Beverage	Undisputed	01/23/2026	1139769278	CMS
Incyte Corporation	$22.58	06/17/2024	Food and Beverage	Undisputed	01/23/2026	1141256705	CMS
Janssen Biotech, Inc.	$21.30	01/04/2024	Food and Beverage	Undisputed	01/23/2026	1078534869	CMS
Janssen Biotech, Inc.	$64.95	03/17/2024	Education	Undisputed	01/23/2026	1078535013	CMS
Janssen Biotech, Inc.	$3.26	05/22/2024	Food and Beverage	Undisputed	01/23/2026	1078534865	CMS
Janssen Biotech, Inc.	$19.14	07/29/2024	Food and Beverage	Undisputed	01/23/2026	1078535489	CMS
Janssen Biotech, Inc.	$3.33	07/29/2024	Food and Beverage	Undisputed	01/23/2026	1078535604	CMS
Janssen Biotech, Inc.	$20.76	08/19/2024	Food and Beverage	Undisputed	01/23/2026	1078535588	CMS
Janssen Biotech, Inc.	$6.70	12/06/2024	Food and Beverage	Undisputed	01/23/2026	1078535425	CMS
Janssen Biotech, Inc.	$16.07	12/09/2024	Food and Beverage	Undisputed	01/23/2026	1078535088	CMS
Lilly USA, LLC	$18.94	01/10/2024	Food and Beverage	Undisputed	01/23/2026	1135027840	CMS
Lilly USA, LLC	$18.16	03/18/2024	Food and Beverage	Undisputed	01/23/2026	1135027322	CMS
Lilly USA, LLC	$27.04	05/06/2024	Food and Beverage	Undisputed	01/23/2026	1135027324	CMS
Lilly USA, LLC	$17.55	07/22/2024	Food and Beverage	Undisputed	01/23/2026	1135043624	CMS
MAYNE PHARMA COMMERCIAL LLC	$15.09	01/31/2024	Food and Beverage	Undisputed	01/23/2026	1154698611	CMS
Novartis Pharmaceuticals Corporation	$6.80	01/18/2024	Food and Beverage	Undisputed	01/23/2026	1086718885	CMS
Novartis Pharmaceuticals Corporation	$18.60	02/12/2024	Food and Beverage	Undisputed	01/23/2026	1086718887	CMS
Novartis Pharmaceuticals Corporation	$22.32	04/01/2024	Food and Beverage	Undisputed	01/23/2026	1086718891	CMS
Novartis Pharmaceuticals Corporation	$3.98	04/09/2024	Food and Beverage	Undisputed	01/23/2026	1086718893	CMS
Novartis Pharmaceuticals Corporation	$20.29	04/29/2024	Food and Beverage	Undisputed	01/23/2026	1086718897	CMS
Novartis Pharmaceuticals Corporation	$4.61	05/20/2024	Food and Beverage	Undisputed	01/23/2026	1086718901	CMS
Novartis Pharmaceuticals Corporation	$19.83	06/03/2024	Food and Beverage	Undisputed	01/23/2026	1086718903	CMS
Novartis Pharmaceuticals Corporation	$16.94	07/11/2024	Food and Beverage	Undisputed	01/23/2026	1086718905	CMS
Novartis Pharmaceuticals Corporation	$21.72	07/15/2024	Food and Beverage	Undisputed	01/23/2026	1086718907	CMS
Novartis Pharmaceuticals Corporation	$30.12	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1086718915	CMS
PFIZER INC.	$23.57	02/08/2024	Food and Beverage	Undisputed	01/23/2026	1131716772	CMS
PFIZER INC.	$22.36	04/25/2024	Food and Beverage	Undisputed	01/23/2026	1131716146	CMS
PFIZER INC.	$24.88	10/22/2024	Food and Beverage	Undisputed	01/23/2026	1132102307	CMS
Regeneron Healthcare Solutions, Inc.	$27.47	01/12/2024	Food and Beverage	Undisputed	01/23/2026	1114026626	CMS
Regeneron Healthcare Solutions, Inc.	$34.01	04/03/2024	Food and Beverage	Undisputed	01/23/2026	1114026628	CMS
Regeneron Healthcare Solutions, Inc.	$14.40	10/01/2024	Food and Beverage	Undisputed	01/23/2026	1114026630	CMS
Regeneron Healthcare Solutions, Inc.	$24.22	10/28/2024	Food and Beverage	Undisputed	01/23/2026	1114026632	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.